Navigation Links
Cohera Medical Names Richard L. Wonsettler as Company's First CFO
Date:6/30/2008

PITTSBURGH, June 30 /PRNewswire/ -- Cohera Medical Inc. today named Richard L. Wonsettler to the newly created position of vice president of finance and CFO.

The addition of Wonsettler, who has nearly 20 years of financial management experience with emerging private and public companies, comes at a time that Cohera Medical is preparing to enter the clinical stage of development with its lead surgical adhesive product, TissuGlu(R).

"We are entering an important phase in the company's growth," said Patrick Daly, president and CEO of Cohera Medical. "In conjunction with our product development activities, we are ramping up our financing activities. Richard has the proven experience in working with companies in positions similar to ours. He will be integral to our plans moving forward."

Prior to joining Cohera Medical, Wonsettler was the CFO and treasurer of Active Media/ClubCom Inc., venture-capital-backed, start-up companies in Pittsburgh for which he built the accounting and treasury departments. Before this, Wonsettler worked with Wexford, Penn.-based SMT Health Services Inc. (SMT) as CFO and treasurer. He was the head of SMT's finance department when the company was owned by private equity firm Apollo Management L.P. Earlier in his career, Wonsettler was an audit professional with KPMG L.L.P. in Pittsburgh.

Wonsettler is a certified public accountant. He received a bachelor's degree in accounting, summa cum laude, from Washington and Jefferson College in Washington, Penn.

About Cohera Medical

Cohera Medical Inc. is a Pittsburgh-based company that is developing a revolutionary line of wound management products and surgical adhesives. Cohera Medical's products are based on a unique chemical design that is purely synthetic, easy to use, biocompatible and fully resorbable. The company's lead product in development, TissuGlu, is a sprayable bonding agent for plastic surgery procedures. TissuGlu adheres flaps of tissue after surgical procedures, eliminating the spaces where fluid accumulates and reducing wound drainage. Cohera Medical is also developing surgical adhesives targeting mesh fixation and small bone fixation, which will fill similar market needs in both orthopedics and general surgery. For more information, visit http://www.coheramed.com. TissuGlu and the other Cohera products have not yet been approved for medical use by the Food and Drug Administration (FDA) in the U.S. or by any other country's regulatory authority.

Certain statements made throughout this press release that are not historical facts contain forward-looking statements regarding the Company's future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-looking statements.


'/>"/>
SOURCE Cohera Medical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Data Published in Plastic and Reconstructive Surgery Show Cohera Medicals Surgical Adhesive, TissuGlu(R), Prevents Seroma Formation in Animal Abdominoplasty Model
2. MYSTERY ER Season 2 Takes Viewers Behind the Curtain for Real-Life Medical Mysteries on Discovery Health
3. WaferGens SmartChip(TM) Real-Time PCR System to Begin Alpha Testing at University of Pittsburgh Medical School
4. Southern Home Medical Equipment Completes 1-for-1,000 Reverse Split and Begins Trading Under New Symbol SHOM
5. Medical Machines Online Announces the Overstock and Release of a New ECG Machine
6. Urgent Care Provider NextCare Introduces CareForToday Medical Insurance Plan
7. Grubb & Ellis Healthcare REIT Acquires SouthCrest Medical Plaza in Stockbridge, Ga.
8. Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardiovascular Tests
9. Encore Medical Staffing of Greenville Signs Seventh Staffing Agreement
10. Pathway Medical Technologies Awarded New Patent for Pathway PV(TM) Atherectomy System for Improved Differential Cutting
11. Exclusive Resort Community Looks to MedeFile to Provide Members With Access to Medical Records Anytime, Anywhere
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... Florida (PRWEB) , ... April 24, 2017 , ... My ... teas, announced its products are now available for purchase on RevNutrition.com, a popular website ... of tea first produced and popularized in ancient India and Siam. It spread across ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... recognize elevated anxiety levels in people with addiction who are served by MAP’s ... a biosensing wearable device that monitors heart and breath rates to identify anxiety ...
(Date:4/24/2017)... Switzerland (PRWEB) , ... April 24, 2017 , ... ... steps to become familiar. This makes it difficult for lab operators and management ... systematic methodology to help them identify wasteful or unnecessary actions. , Created ...
(Date:4/24/2017)... ... , ... “The Saint with Trin, and Omega Station”: a triple feature offering ... of published author, Chris Jackson. Chris Jackson grew up in Abilene, Texas. ... School District teaching English. He is heavily involved in the youth group of his ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... laboratory-grade deionized water from the same place. From 101 Water Texas, here are ... Patients and staff can enjoy a continuous supply of pure, fresh, oxygenated water, ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... YORK , April 19, 2017 ... This report on the prostate cancer therapeutics ... the global market. Increasing prevalence of prostate cancer, ... innovation in the development of new drugs & ... prostate cancer drug due to lesser side effects ...
(Date:4/19/2017)... LONDON , April 19, 2017 ... to stimulate an immune response in pets such ... vaccine products are of various types such as ... Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. ... such as virus or bacteria, which have been ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
Breaking Medicine Technology: